Ki Woong Sung
Overview
Explore the profile of Ki Woong Sung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
1981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seo E, Jeong I, Ju H, Hyun J, Lee J, Yoo K, et al.
Front Immunol
. 2025 Feb;
16:1517387.
PMID: 39967668
Introduction: The Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) model is a recently developed algorithm that predicts indirect T-cell recognition by calculating the number of such epitopes in donor-recipient pairs. Methods:...
2.
Seo E, Jeong I, Ju H, Hyun J, Lee J, Yoo K, et al.
Front Immunol
. 2025 Feb;
16:1565304.
PMID: 39967655
[This corrects the article DOI: 10.3389/fimmu.2025.1517387.].
3.
Seo E, Lee J, Lim J, Shin S, Cho H, Ju H, et al.
Nat Commun
. 2024 Sep;
15(1):8360.
PMID: 39333105
Germline genetic context may play a significant role in the development and evolution of cancer, particularly in childhood cancers such as neuroblastoma. This study investigates the role of putatively functional...
4.
Ju H, Lee N, Yi E, Choi Y, Kim S, Hyun J, et al.
Cancer Res Treat
. 2024 Jul;
57(1):240-249.
PMID: 38965922
Purpose: Hematopoietic stem cell transplantation (HSCT) has been an important method of treatment in the advance of pediatric acute lymphoblastic leukemia (ALL). The indications for HSCT are evolving and require...
5.
Seo E, Lee J, Cho H, Ju H, Cho Y, Lee S, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(9):e31173.
PMID: 38965702
Background: Tandem high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT) and incorporation of I-metaiodobenzylguanidine (I-MIBG) treatment have shown positive outcomes in high-risk neuroblastoma. However, more optimized treatment strategies are still...
6.
Yang K, Ahn J, Woo S, Jung S, Sung K, Lee J, et al.
BMC Pediatr
. 2024 May;
24(1):372.
PMID: 38811872
Background: To evaluate the effects of local radiotherapy (RT) on growth, we evaluated the chronological growth profiles and vertebral features of children with high-risk neuroblastoma. Methods: Thirty-eight children who received...
7.
Bang M, Lee S, Lee J, Kim W, Sung K, Seo J
Asian J Surg
. 2024 Mar;
47(6):2584-2588.
PMID: 38519312
Background: We calculated psoas muscle area (PMA) z-scores in high-risk neuroblastoma patients undergoing treatment to examine the clinical significance of sarcopenia in this cohort. Methods: We analyzed retrospective data from...
8.
Lim H, Im M, Seo E, Cho H, Ju H, Yoo K, et al.
Cancer Res Treat
. 2023 Nov;
56(2):642-651.
PMID: 37997325
Purpose: This study aimed to investigate the incidence and risk factors for secondary malignant neoplasms (SMN) in pediatric solid tumors, focusing on the effects of tandem high-dose chemotherapy (HDCT). Materials...
9.
Lee J, Ju H, Hyun J, Kim S, Cho H, Lee J, et al.
Blood Res
. 2023 Nov;
58(4):181-186.
PMID: 37926557
Background: Despite improved outcomes for pediatric patients with acute myeloid leukemia (AML), the prognosis for relapse remains poor. This study aimed to examine the clinical factors associated with prognosis in...
10.
Lee J, Yeo Y, Ju H, Cho H, Yoo K, Sung K, et al.
J Korean Med Sci
. 2023 Jul;
38(29):e230.
PMID: 37489718
Background: Data on the status of long-term follow-up (LTFU) care for childhood cancer survivors (CCSs) in Korea is lacking. This study was conducted to evaluate the current status of LTFU...